European Consumers Use of Internet for Pharmaceutical Information

Manhattan ResearchIn today's world of fragmented media and channel mix, it is increasingly difficult to isolate the information sources used by consumers to research health information and inform healthcare decision making. This is especially the case across Europe, where consumers are accessing an expanding range of resources which vary greatly by country and by region.

Enter Cybercitizen® Health Europe, a new research study and advisory service offered by Manhattan Research. This study provides pharmaceutical and healthcare companies with key data about the evolving nature of consumer channel mix, media and technology usage, and healthcare information with the goal of helping companies understand how consumers across Europe access health information, and how they use that information to make critical healthcare decisions for themselves and their families.

In addition to defining broad online health technology trends, Cybercitizen® Health Europe will investigate topics such as Internet usage, search engine usage, local European versus global websites, product websites, health portals, health information seeking methods, email communication, patient-physician interactions, unbranded patient education, health e-commerce and more. Furthermore, the study will reveal leading health and pharma websites based on the number of visiting European consumers, while detailing consumer satisfaction with site content and features.

Webinar Presentation
A free, private webinar is offered to qualified business accounts to review additional information about Cybercitizen® Health Europe as well as charter sponsorship details. Please visit www.manhattanresearch.com/ccheu.aspx to register for the webinar or to request additional information.

The Cybercitizen® Health Europe syndicated multi-client study and advisory service will be fielded as an online panel study among 3,300 European consumers in total from the United Kingdom, Germany, Spain, Italy, France, Belgium, Sweden, the Netherlands, Poland, and Portugal. The study will explore these topics and many more:

  • Overall media consumption
  • Frequency and types of Internet access
  • Technology adoption like MP3/iPod, PDA, SMS messaging, Smartphones
  • Advanced activities online like online video, blogs, podcasting, wikis
  • Use and relative influence of physicians, nurses, pharmacists, friends and family
  • Search engine reliance and behaviour
  • Use and interest in health email newsletters, support groups, chat rooms, and disease management tools
  • Interest in Web 2.0 technologies for health and pharmaceutical information

About Manhattan Research Products and Service
In addition to Cybercitizen® Health Europe, Manhattan Research conducts five annual research studies among consumers and physicians in the United States and in Europe. These studies include Cybercitizen® Health US, Taking the Pulse® Europe, Taking the Pulse® US, ePharma Physician®, and ePharma Consumer®. Each study serves a unique purpose and focuses on specific aspects of information technology adoption. Broad consumer and physician research is complemented by targeted analysis among more than 50 consumer therapeutic segments and 25 physician specialist segments. For further information, please visit www.manhattanresearch.com

Most Popular Now

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...

New AI Tool Makes Medical Imaging Proces…

When doctors analyze a medical scan of an organ or area in the body, each part of the image has to be assigned an anatomical label. If the brain is...